Androstenedione metabolism in patients with endometrial cancer.
The plasma concentration of androstenedione and the instantaneous conversion of androstenedione to estrone was increased in patients with endometrial cancer as compared to postmenopausal control subjects. Moreover, the per cent of estrone derived from androstenedione was increased in the cancer group.
D000735:Androstenedione / Q000097:blood*; D004958:Estradiol / Q000097:blood; D004970:Estrone / Q000097:blood; D005260:Female; D006801:Humans; D008593:Menopause; D008657:Metabolic Clearance Rate; D013739:Testosterone / Q000097:blood; D014594:Uterine Neoplasms / Q000097:blood*
D004970:Estrone; D013739:Testosterone; D000735:Androstenedione; D004958:Estradiol